Cingulate Inc.

NASDAQ:CING

Biotechnology

Healthcare
$5.11 -0.95%

-$0.05 today

Market cap
$76.46M
Beta
-0.91
P/E (TTM)
-1.0
EPS (TTM)
-$5.10
52W Low $3.16High $11.89

Volume 0.95M

Average 0.46M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$17.25M

FY 2025 · Annual

Investing Cash Flow

-$162,000.00

FY 2025 · Annual

Financing Cash Flow

$16.15M

FY 2025 · Annual

-47.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(20.71M)(17.68M)(23.53M)(15.55M)(22.45M)
Depreciation & Amortization708.32K394.01K582.92K653.09K540.89K
Deferred Income Tax(16.26M)(797.96K)000
Stock-Based Compensation12.78M800.8K812.67K995.48K0
Change in Working Capital(3.21M)598.62K7.1M(4.55M)830.85K
Accounts Receivables(1.86M)1.25M219.81K(11.7K)18.31K
Inventory0(1.25M)000
Accounts Payables0791.01K000
Other Working Capital(1.35M)(192.39K)6.89M(4.54M)812.54K
Other Non-Cash Items16.26M797.96K003.83M
Operating Cash Flow(10.43M)(15.88M)(15.03M)(18.45M)(17.25M)
Capital Expenditures(814.74K)(153.42K)(224.1K)(211.8K)(162.14K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments0933000
Other Investing Activities0(165)00138
Investing Cash Flow(814.74K)(152.65K)(224.1K)(211.8K)(162K)
Debt Repayment(936.59K)4.98M2.98M4.95M6M
Common Stock Issued20.37M(85.92K)6.97M25.88M10.15M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities7.1M000(382)
Financing Cash Flow26.54M4.9M9.95M30.82M16.15M
Effect of Forex Changes00000
Net Change in Cash15.3M(11.14M)(5.3M)12.16M(1.26M)
Free Cash Flow(11.25M)(16.04M)(15.26M)(18.66M)(17.41M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$22.4M
+ D&A$540.9K
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$830.9K
+ Other Non-Cash$3.8M
= Operating Cash Flow-$17.2M
- Capex-$162.1K
= Free Cash Flow-$17.4M

Analysis

FY2025 free cash flow is -$17.4M. FCF conversion is 77.5% of net income. Operating cash flow was -$17.2M, with capex of -$162.1K. The largest bridge item is Other Non-Cash at $3.8M.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
424B3424B3 filingNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

Does CING generate free cash flow?

Cingulate Inc. (CING) generated -$17.41M of free cash flow in fiscal 2025.

How much operating cash flow does CING produce?

Operating cash flow was -$17.25M, before capital expenditures of $162,138.00.